Crossmark

Target Hyperactive ERK Signaling for Cancer Therapy

Crossref DOI link: https://doi.org/10.1007/978-3-030-80962-1_257-1

Published Online: 2023-04-08

Published Print: 2023

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Jiajun, Yap

Jiancheng, Hu
License Information

Text and Data Mining valid from 2023-01-01

Version of Record valid from 2023-01-01
More Information

Chapter History

Received: 12 May 2022, 00:00:00

Accepted: 22 July 2022, 00:00:00

First Online: 8 April 2023